A non-randomized risk-adjusted comparison of lenalidomide plus R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

de Jonge, AV; van Werkhoven, E; Dinmohamed, AG; Nijland, M; Zwinderman, AH; Bossuyt, PM; Veldhuis, MS; Rutten, EGGM; Mous, R; Vermaat, JSP; Sandberg, Y; de Jongh, E; Bilgin, YM; Boersma, R; Koene, H; Kersten, MJ; de Jong, D; Chamuleau, MED

de Jonge, AV (通讯作者)，Amsterdam UMC Locat VU, Dept Hematol, Amsterdam, Netherlands.

BLOOD CANCER JOURNAL, 2023; 13 (1):

Abstract

Patients with MYC rearranged (MYC-R) diffuse large B-cell lymphoma (DLBCL) have a poor prognosis. Previously, we demonstrated in a single-arm phase II......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索